Polyarticular Severe Tophaceous Gout Secondary to Limited Medication Access ANAND KUMTHEKAR, MD, Resident Physician andBEVERLY JOHNSON, MD, MPH, Patients in the United States without private medical
ANAND KUMTHEKAR, MD, Resident Physician⇑andBEVERLY JOHNSON, MD, MPH,
Patients in the United States without private medical insurance and who do not qualify for patient assistance programs sometimes have no access to needed medications. The most effective drugs for severe tophaceous gout may be beyond the reach of these patients.
A 49-year-old undocumented male Mexican immigrant presented to the emergency room with foot pain, left greater than right. He had a history of chronic diffuse tophaceous gout (Figure
The Journal of Rheumatology vol. 42no. 81528-1529
copyright© 版权所有,未经许可不得复制、转载或镜像
京ICP证120392号 京公网安备110105007198 京ICP备10215607号-1 (京)网药械信息备字(2022)第00160号